The US Food and Drug Administration has been enthusiastic about the potential use of real-world evidence in the COVID-19 arena. But a former official of the Department of Health and Human Services thinks the government has missed an opportunity to advance the use of real-world data for vaccine safety surveillance.
Nicole Lurie, strategic adviser to the Coalition for Epidemic Preparedness Innovation (CEPI) and former assistant secretary for preparedness and response...








